RxDoctor Payments Data

Mara Tijerina

Family · la Jolla, CANPI 1801501838

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.9% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations.

$1,635in general payments, 2019–2025

Across 63 payments — averaging $25.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$362
  • Pharmaessentia USA Corporation$196
  • Pfizer$164
  • AstraZeneca$117
  • Array Biopharma Inc$76
  • Merck$73
  • plus $647 from 17 others

What the payments were for

  • Food & beverage$1,53694%
  • Education$996%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,635 in reported general payments places this provider in the 80th percentile of 10,634 family providers in California.

See all family providers in California →

Other family in la Jolla

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →